CompletedNCT06267846
What is this study about?Researchers compared NBI-1070770 and placebo to find out how the approaches affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Neurocrine Biosciences (Biotech company)
CompletedNCT05685758
Official study titleA Treatment for Depression Via App-Based FTP (Game4Mood Study)
This study has finished and is no longer accepting participants.
In BostonDepressionInterventional studyAges 20–50
- Countries
- United States
- Sponsor
- Hedonia Ltd
CompletedNCT06372210
Official study titleAn Open-label, Prospective Trial Assessing Positive Detection Accuracy and Detection Latency Measures of the Miniature Ingestible Event Marker Tablet Using the D-Tect Patch in Healthy Subjects and Assessing Detection Latency Measures Using the D-Tect Patch in Subjects With Serious Mental Illness Taking Abilify MyCite Tablet
This study has finished and is no longer accepting participants.
In Garden GroveDepression, Schizophrenia, ...Medication studyAges 18+
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT07553130
Official study titleValidation of the acceXible Screening and Monitoring System for Depression and Anxiety in the Student Population of the Benemérita Universidad Autónoma de Puebla (BUAP)
This study has finished and is no longer accepting participants.
In Puebla CityDepression, AnxietyObservational studyAges 16–25
- Countries
- Mexico
- Sponsor
- Accexible
CompletedNCT01441258
Official study titleAdaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and Depression
This study has finished and is no longer accepting participants.
In BostonDepression, SuicidalityBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Maurizio Fava, MD
WithdrawnNCT00993629
Official study titleAdjunctive Pregnenolone in PTSD and Depression in OEF/OIF Veterans
This study was withdrawn before enrollment.
In DurhamDepression, PTSDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- US Department of Veterans Affairs
UnknownNCT05384405
Official study titleAccelerated Intermittent Theta Burst Stimulation for the Treatment of Non-suicidal Self-injury in Patients With Unipolar Depression and Bipolar Depression: a Sham-controlled Study
Current recruitment status is unconfirmed.
In ChangshaDepression, BipolarityDevice studyAges 12–18
- Countries
- China
- Sponsor
- Central South University
UnknownNCT06452849
Official study titleTemporal Interference Stimulation of Amygdala and dLPFC: A Randomized Controlled Trial for Adolescent Depression
Current recruitment status is unconfirmed.
In ShanghaiDepressionDevice studyAges 14–18
- Countries
- China
- Sponsor
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
UnknownNCT06461260
Official study titleSafety, Efficacy and Neuroimaging Mechanisms of Amygdala Temporal Interference Stimulation Therapy for Depression
Current recruitment status is unconfirmed.
In ShanghaiDepressionDevice studyAges 18–65
- Countries
- China
- Sponsor
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
CompletedNCT06477276
Official study titleA Multicenter, Randomized, Controlled, Double-Blind Trial on the Efficacy and Safety of Amygdala Temporal Interference Stimulation for the Treatment of Depression.
This study has finished and is no longer accepting participants.
Multiple locations, including ShanghaiDepressionDevice studyAges 18–65
- Countries
- China
- Sponsor
- Ruijin Hospital
CompletedNCT07017569
Official study titleDesign and Development of an Interactive Mobile Health (mHealth) App to Provide Momentary and Periodic Intervention for High Anxiety and Depression
This study has finished and is no longer accepting participants.
In College StationDepression, AnxietyBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Texas A&M University
Active Not RecruitingNCT06922110
What is this study about?Researchers are studying Azetukalner, tracking side effects to assess long-term safety and tolerability in people with depression.
This study is no longer accepting new participants.
Multiple locations, including PhoenixDepressionMedication studyAges 18+
- Countries
- United States, Finland, Poland
- Sponsor
- Xenon Pharmaceuticals Inc.